Expression of Axl in lung adenocarcinoma and correlation with tumor progression

Neoplasia

Volumn 7, Issue 12, 2005, Pages 1058-1064

  Shieh, Yi Shing ^a,b   Lai, Chiung Ya ^c   Kao, Yu Rung ^c   Shiah, Shine Gwo ^c   Chu, Yi Wen ^c   Lee, Herng Sheng ^b   Wu, Cheng Wen ^a,c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Adenocarcinoma; Cancer invasion; Microarray; Transfection; Tyrosine receptor kinase

Indexed keywords

PROTEIN KINASE; PROTEIN KINASE AXL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; AXL RECEPTOR TYROSINE KINASE; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL LINE; CONTROLLED STUDY; CORRELATION FUNCTION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ADENOCARCINOMA; CANCER STAGING; CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE STUDY; DISEASE COURSE; DNA MICROARRAY; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; ENZYMOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; LUNG TUMOR; LYMPH NODE; MALE; METABOLISM; PATHOLOGY;

ADENOCARCINOMA; CELL DIFFERENTIATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPH NODES; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 33644876133     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05640     Document Type: Article

References (27)

1. MacDonald NJ and Steeg PS (1993). Molecular basis of tumor metastasis. Cancer Surv 16, 175-199.
2. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R, and Wu CW (1997). Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 117, 353-360.
3. O'Donnell K, Harkes IC, Dougherty L, and Wicks IP (1999). Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol 154, 1171-1180.
4. Janssen JW, Schulz AS, Steenvoorden AC, Schmidberger M, Strehl S, Ambros PF, and Bartram CR (1991). A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene 6, 2113-2120.
5. O'Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa R III, Le Beau MM, Earp HS, and Liu ET (1991). Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 11, 5016-5031.
6. Schneider C, King RM, and Philipson L (1988). Genes specifically expressed at growth arrest of mammalian cells. Cell 54, 787-793.
7. Manfioletti G, Brancolini C, Avanzi G, and Schneider C (1993). The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K- dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 13, 4976-4985.
8. Valverde P, Obin MS, and Taylor A (2004). Role of Gas6/Axl signaling in lens epithelial cell proliferation and survival. Exp Eye Res 78, 27-37.
9. Goruppi S, Ruaro E, and Schneider C (1996). Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 12, 471-480.
10. Goruppi S, Ruaro E, Varnum B, and Schneider C (1997). Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol 17, 4442-4453.
11. Goruppi S, Ruaro E, Varnum B, and Schneider C (1999). Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene 18, 4224-4236.
12. Quong RY, Bickford ST, Ing YL, Terman B, Herlyn M, and Lassam NJ (1994). Protein kinases in normal and transformed melanocytes. Melanoma Res 4, 313-319.
13. Chen WS, Kung HJ, Yang WK, and Lin W(1999). Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa. Int J Cancer 83, 579-584.
14. Ito T, Ito M, Naito S, Ohtsuru A, Nagayama Y, Kanematsu T, Yamashita S, and Sekine I (1999). Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma. Thyroid 9, 563-567.
15. Meric F, Lee WP, Sahin A, Zhang H, Kung HJ, and Hung MC (2002). Expression profile of tyrosine kinases in breast cancer. Clin Cancer Res 8, 361-367.
16. Challier C, Uphoff CC, Janssen JW, and Drexler HG (1996). Differential expression of the ufo/axl oncogene in human leukemia-lymphoma cell lines. Leukemia 10, 781-787.
17. Berclaz G, Altermatt HJ, Rohrbach V, Kieffer I, Dreher E, and Andres AC (2001). Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast. Ann Oncol 12, 819-824.
18. Lin WC, Li AF, Chi CW, Chung WW, Huang CL, Lui WY, Kung HJ, and Wu CW (1999). Tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer. Clin Cancer Res 5, 1745-1751.
19. Jacob AN, Kalapurakal J, Davidson WR, Kandpal G, Dunson N, Prashar Y, and Kandpal RP (1999). A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145. Cancer Detect Prev 23, 325-332.
20. Craven RJ, Xu LH, Weiner TM, Fridell YW, Dent GA, Srivastava S, Varnum B, Liu ET, and Cance WG (1995). Receptor tyrosine kinases expressed in metastatic colon cancer. Int J Cancer 60, 791-797.
21. Kao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL, Chu YW, Yang PC, Wu CW, and Roffler SR (2003). Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res 9, 2807-2816.
22. Chen JJ, Wu R, Yang PC, Huang JY, Sher YP, Han MH, Kao WC, Lee PJ, Chiu TF, Chang F, et al. (1998). Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection. Genomics 51, 313-324.
23. Shih JY, Lee YC, Yang SC, Hong TM, Huang CY, and Yang PC (2003). Collapsin response mediator protein-1: a novel invasion-suppressor gene. Clin Exp Metastasis 20, 69-76.
24. Wu CW, Li AF, Chi CW, Lai CH, Huang CL, Lo SS, Lui WY, and Lin WC (2002). Clinical significance of AXL kinase family in gastric cancer. Anticancer Res 22, 1071-1078.
25. Hanahan D and Weinberg RA (2000). The hallmarks of cancer. Cell 100, 57-70.
26. Wimmel A, Glitz D, Kraus A, Roeder J, and Schuermann M (2001). Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion. Eur J Cancer 37, 2264-2274.
27. Rochlitz C, Lohri A, Bacchi M, Schmidt M, Nagel S, Fopp M, Fey MF, Herrmann R, and Neubauer A (1999). Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK). Leukemia 13, 1352-1358.